CEO Blueberry Therapeutics @ (November 2011 - February 2024)
CEO and Board Member @ (April 2012 - May 2022)
Director Discovery Sciences iMED @ (February 2001 - April 2012)
Senior Principle Scientist @ (January 1995 - March 2001)
Laboratory Head @ Ribonetics Ltd (January 1993 - January 1995)
Postdoctoral Scientist @ Ludwig institute and Cancer Research UK (June 1989 - May 1993)
John Ridden Education
University of Oxford
DPhil (Biochemistry)
1986-1989
John Ridden Skills
Leadership
Drug Discovery
Team Building
Protein Chemistry
Pharmaceutical Industry
Lifesciences
Biopharmaceuticals
Clinical Development
Immunology
R&D
Cell
Drug Delivery
Oncology
Dermatology
Science
Peptides
Medicine
Pharmacology
Molecular Biology
Biotechnology
Biomarker Discovery
Cell Biology
Drug Development
Inflammation
Life Sciences
Research and Development (R&D)
Biodiversity
Infectious Diseases
Management
Business Development
Biochemistry
Development
Microsoft Office
Business Strategy
Research
Research and Development R&d
Research and Development
John Ridden Summary
John Ridden, based in Nether Alderley, GB, is currently a Chief Scientific Officer at LivFul, Inc.. John Ridden brings experience from previous roles at Quodria Ltd, Ton, Blueberry Therapeutics Ltd and Tecrea Ltd. John Ridden holds a 1986 - 1989 DPhil in Biochemistry @ University of Oxford. With a robust skill set that includes Leadership, Drug Discovery, Team Building, Protein Chemistry, Pharmaceutical Industry and more. John Ridden has 2 emails on RocketReach.
Looking for a different John Ridden?
Find contact details for 700 million professionals.